BI-RADS 3 乳腺病灶女性中获得最佳随访的相关因素
该回顾性队列研究纳入2016年在一家学术医学中心接受乳腺影像检查(超声和乳腺X线)的女性,评估BI-RADS 3病灶的最佳随访率及相关因素。在1511例BI-RADS 3患者中,1125例(74%)实现了最佳随访;既往乳腺癌与最佳随访相关,而年轻、西班牙裔、离异状态和无保险与未获得最佳随访相关。恶性率为0.86%,平均检出时间为330天。
要点
- BI-RADS 3病灶的最佳随访率仅74%,即1511例中1125例在3至9个月内对同侧乳腺进行了随访影像检查。
- 既往乳腺癌患者更可能获得最佳随访;年轻、西班牙裔、离异、无保险者更可能未获得最佳随访。
- BI-RADS 3病灶的恶性率为0.86%,平均检出时间为330天。
核心结论
- BI-RADS 3乳腺影像病灶的随访仅在74%的女性中达到最佳;促进随访的干预措施应针对年轻、未婚、西班牙裔、无乳腺癌病史和无保险覆盖的女性。
研究设计与样本
- 经机构审查委员会批准的回顾性队列研究,在一家学术医学中心进行,纳入2016年所有接受乳腺影像检查(超声和乳腺X线)的女性;通过自然语言处理检索BI-RADS 3评估的索引报告,从研究数据仓库提取患者和提供者特征,由机构癌症登记处识别乳腺癌患者。
诊断标准与关键数值
- 最佳随访率定义为BI-RADS 3评估患者中在索引检查后3至9个月内对同侧乳腺进行随访影像检查的患者比例;共93685次乳腺影像检查,来自64771例 unique 患者,其中2967例(4.6%)有BI-RADS 3发现;排除异地索引检查和索引后3个月内另一次乳腺检查的患者后,1511例中1125例(74%)获得最佳随访;恶性率为0.86%,平均检出时间为330天。
临床应用与阅片要点
- 作者建议进一步干预以促进随访,应针对年轻、未婚女性、西班牙裔女性、无乳腺癌病史和无保险覆盖的女性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Assess rate of and factors associated with optimal follow-up in patients with BI-RADS 3 breast findings.
METHODS: This Institutional Review Board-approved, retrospective cohort study, performed at an academic medical center, included all women undergoing breast imaging (ultrasound and mammography) in 2016. Index reports for unique patients with an assessment of BI-RADS 3 (retrieved via natural language processing) comprised the study population. Patient-specific and provider-related features were extracted from the Research Data Warehouse. The Institutional Cancer Registry identified patients diagnosed with breast cancer. Optimal follow-up rate was calculated as patients with follow-up imaging on the same breast 3 to 9 months from the index examination among patients with BI-RADS 3 assessments. Univariate analysis and multivariable logistic regression determined features associated with optimal follow-up. Malignancy rate and time to malignancy detection were recorded.
RESULTS: Among 93,685 breast imaging examinations, 64,771 were from unique patients of which 2,967 had BI-RADS 3 findings (4.6%). Excluding patients with off-site index examinations and those with another breast examination <3 months from the index, 1,125 of 1,511 patients (74%) had optimal follow-up. In univariate and multivariable analysis, prior breast cancer was associated with optimal follow-up; younger age, Hispanic ethnicity, divorced status, and lack of insurance were associated with not having optimal follow-up. Malignancy rate was 0.86%, and mean time to detection was 330 days.
DISCUSSION: Follow-up of BI-RADS 3 breast imaging findings is optimal in only 74% of women. Further interventions to promote follow-up should target younger, unmarried women, those with Hispanic ethnicity, and women without history of breast cancer and without insurance coverage.
引用
- Lacson R, Wang A, Cochon L, et al. Factors Associated With Optimal Follow-up in Women With BI-RADS 3 Breast Findings. J Am Coll Radiol. 2019. PMID: 31669081. doi:10.1016/j.jacr.2019.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。